Preferential inhibitory effect of soluble factor(s) in human bone marrow stromal cells on proliferation of K562 leukemia cells versus normal myeloid progenitor cells
スポンサーリンク
概要
著者
-
AOYAGI Arina
Department of Hematology, Dokkyo University School of Medicine
-
Furusawa Shinpei
Department Of Hematology Dokkyo Medical School Of Medicine
-
Furusawa Shinpei
Department Of Hematology Dokkyo University School Of Medicine
-
WAGA Kazuo
Third Department of Internal Medicine, Dokkyo University School of Medicine
-
ENOKIHARA Hideo
Third Department of Internal Medicine, Dokkyo University School of Medicine
-
FURUSAWA Shinpei
Third Department of Internal Medicine, Dokkyo University School of Medicine
-
Waga Kazuo
Department Of Hematology Dokkyo University School Of Medicine
-
Aoyagi Arina
Department Of Hematology Dokkyo University School Of Medicine
-
Enokihara Hideo
Third Department Of Internal Medicine Dokkyo University School Of Medicine
-
Furusawa S
Department Of Hematology Hamamatsu Medical Center
-
AOYAGI Arina
Third Department of Internal Medicine, Dokkyo University School of Medicine
-
AOYAGI Masakuni
Third Department of Internal Medicine, Dokkyo University School of Medicine
-
Aoyagi Masakuni
Department Of Hematology Dokkyo University School Of Medicine
関連論文
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Spicamycin and KRN5500 Induce Apoptosis in Myeloid and Lymphoid Cell Lines with Down-regulation of Bcl-2 Expression and Modulation of Promyelocytic Leukemia Protein
- A variant transcript, e1a3, of the minor BCR-ABL fusion gene in acute lymphoblastic leukemia : case report and review of the literature
- Glucocorticoid-Induced Apoptotic Pathways in Eosinophils: Comparison With Glucocorticoid-Sensitive Leukemia Cells
- Low-Dose Cytarabine and Aclarubicin in Combination With Granulocyte Colony-Stimulating Factor (CAG Regimen) for Previously Treated Patients With Relapsed or Primary Resistant Acute Myelogenous Leukemia (AML) and Previously Untreated Elderly Patients With
- CD7/CD19 Double-Positive T-Cell Acute Lymphoblastic Leukemia
- Efficacy of a New Formulation of Lenograstim (Recombinant Glycosylated Human Granulocyte Colony-Stimulating Factor) Containing Gelatin for the Treatment of Neutropenia After Consolidation Chemotherapy in Patients With Acute Myeloid Leukemia
- CD5^+ Diffuse Large B-Cell Lymphoma with c-myc/IgH Rearrangement Presenting as Primary Effusion Lymphoma
- Mature and immature myeloid cells decrease the granulocyte colony-stimulating factor level by absorption of granulocyte colony-stimulating factor
- Direct evidence of altered bone metabolixm caused by all-trans retinoic acid
- Low Frequency of BCL10 Gene Mutations in B-Cell Non-Hodgkin's Lymphoma
- Preferential inhibitory effect of soluble factor(s) in human bone marrow stromal cells on proliferation of K562 leukemia cells versus normal myeloid progenitor cells
- Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis